# Levofloxacin in the Treatment of Chronic Functional Constipation Associated With PIB(Peristaltic Contraction-Inhibiting Bacterium) Infection

> **NCT06571097** · NA · RECRUITING · sponsor: **Haifeng Lan** · enrollment: 50 (estimated)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** Levofloxacin

## Key facts

- **NCT ID:** NCT06571097
- **Lead sponsor:** Haifeng Lan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06571097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06571097, "Levofloxacin in the Treatment of Chronic Functional Constipation Associated With PIB(Peristaltic Contraction-Inhibiting Bacterium) Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06571097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*